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Abstract
Background: We previously developed the preliminary version of the Patient-Reported Apnea Questionnaire
(PRAQ), a questionnaire measuring health-related quality of life in patients with (suspected) obstructive sleep apnea
(OSA). This questionnaire was developed for clinical practice, where it can potentially serve two goals: use on an
individual patient level to improve patient care, and use on an aggregate level to measure outcomes for quality
improvement at a sleep center. In this study we aim to finalize the PRAQ, make a subselection of items and
domains specifically for outcome measurement, and assess the validity, reliability and responsiveness of the PRAQ.
Methods: Patients with suspected OSA were included and asked to complete the PRAQ and additional
questionnaires one or more times. The collected data was used to perform the final item selection for clinical
practice and for outcome measurement, create the domains for outcome measurement, and assess the
measurement properties internal consistency, test-retest reliability, convergent validity and responsiveness.
Results: 180 patients were included in the study. The final version of the PRAQ for use in clinical practice contains
40 items and 10 domains. A subselection of 33 items in 5 domains was selected for optimal outcome measurement
with the PRAQ. The results for the outcome measurement domains were: Cronbach’s alpha 0.88–0.95, ICC 0.81–0.88,
and > 75% of hypotheses correct for convergent validity and responsiveness.
Conclusions: The PRAQ shows good measurement properties in patients with (suspected) OSA.
Keywords: Obstructive sleep apnea, Instrument development, Patient-reported outcome measure, Psychometrics
Background
Patients with obstructive sleep apnea (OSA) experience
breathing stops while asleep, causing symptoms during
the day such as excessive sleepiness, tiredness, and irrit-
ability. This can have a large impact on daily functioning
of patients, and often affects a patient’s relationships and
psychological wellbeing [1–3]. Furthermore, OSA is a
known risk factor for comorbidities such as diabetes and
heart failure [4–6], and is also associated with depression
and anxiety [7–9]. Gaining an overview of the problems
that OSA patients may experience, before, during, and
in evaluating treatment, may be a challenge.
Patient-reported outcome measures (PROMs) are ques-
tionnaires for patients about symptoms or daily function-
ing. Most PROMs have been developed for use in clinical
trials, but interest in their use in daily practice is growing
[10, 11]. There, PROM scores can be used on an individual
patient level to help bring patients’ problems to the fore-
front during consultations and to monitor treatment re-
sponse, or on an aggregate level across groups of patients
for quality improvement purposes [12]. Use of a PROM on
an individual patient level may be especially relevant when
patient symptoms are multiple and complex. We therefore
believe that it would be beneficial to employ a PROM for
patients with OSA in daily clinical practice.
In a recently published article, we described the item gen-
eration and preliminary item selection of a PROM for pa-
tients with (suspected) OSA: the Patient-Reported Apnea
Questionnaire (PRAQ) [13]. We used the input of patients
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with OSA and healthcare professionals to select topics and
items important for measuring quality of life for this patient
group, which are also useful to discuss during an intake or
follow-up consultation.
There are two ways in which the preliminary version of
the PRAQ requires further development. First, the item re-
duction for the topic “sleepiness” has not yet taken place.
During the item selection process of the PRAQ, patients in-
dicated that the number of items on the topic of sleepiness
could be reduced. Since the patients had no preference for
which items to exclude, we decided to perform the final
item reduction after studying the psychometric properties
of the items. Second, the factor structure of the PRAQ has
not yet been studied, and we wanted to find the optimal
way to group (a subset of) the items of the PRAQ into do-
mains for the purpose of outcome measurement.
Our aim is for the PRAQ to be employed in the following
way: patients complete all items of the PRAQ before their
consultation, the results of which can be discussed with a
healthcare professional; and the aggregate outcomes of
groups of patients can then be studied by making use of a
subset of the completed items. This is beneficial for pa-
tients, who get feedback from clinicians on their results; for
physicians, who get a quick insight into their patients’ main
problems; and for sleep centers that wish to collect out-
come data for quality improvement, because it ensures a
steady stream of data due to integration in clinical practice.
In this article we describe the further development of the
preliminary PRAQ. In addition, we aim to determine the reli-
ability, validity and responsiveness of the PRAQ, with a focus
on the domains that will be used for outcome measurement.
Methods
Population & method of completion of the PROMs
Baseline measurement
Patients referred to the sleep center of the Albert Scheitzer
Hospital in Dordrecht, The Netherlands for suspected OSA
received an invitation by email to complete the PRAQ and
additional PROMs, 2–3 weeks before their intake consult-
ation. They were informed that the results of the PRAQ
would be discussed during their intake consultation. A re-
minder was sent one week later if the PROMs were not yet
completed at that time. Patients who had not completed
the PRAQ at home were offered the option of completing
the PRAQ at the sleep center before their consultation.
Retest measurement
In order to assess test-retest reliability, patients who had
completed the baseline measurement at home were asked
to complete it again immediately before their intake consult-
ation, on a computer in a private area of the sleep center.
Only patients who had completed the retest no less than 7,
and no more than 21 days after the baseline measurement
were included for assessment of test-retest reliability.
Follow-up measurement
A common measure to express the number of (partial)
breathing stops experienced while asleep is the
Apnea-Hypopnea Index (AHI). We measured the respon-
siveness of the PRAQ in patients with an AHI ≥ 15, which
indicates moderate to severe sleep apnea [14], and who
were prescribed continuous positive airway pressure (CPAP)
after their intake consultation. CPAP is the preferred treat-
ment for OSA [15]. If the patients were still using CPAP at
the time of the first follow-up consultation (6–8 weeks after
start of CPAP), they were included for responsiveness. They
were asked to complete the PRAQ and the additional
PROMs immediately before their follow-up consultation at
the sleep center. Ideally, responsiveness should be deter-
mined in a patient group in which CPAP therapy is success-
ful and therefore a substantial change is expected with
regard to the patient’s symptoms. CPAP therapy is generally
considered successful when compliance is ≥4 h nightly [16].
A secure website was used for the completion of the
PROMs. For any of the measurements, patients who
were unable or unwilling to use a computer were offered
the option of completing a paper copy of the PROMs.
Final stage of PRAQ development
The development article of the preliminary PRAQ [13]
shows how the initial 43 items were selected based on their
relevance for clinical practice and were sorted into prelim-
inary domains: symptoms at night (6 items), sleepiness (8
items), tiredness (3 items), daily activities (5 items), unsafe
situations (2 items), memory and concentration (2 items),
quality of sleep (2 items), emotions (6 items), social interac-
tions (8 items), and health concerns (1 item) (Appendix 1).
All items are scored on a 7-point Likert scale (higher scores
indicate worse problems), and the average item scores in a
domain form its domain score.
First, we performed item reduction on the sleepiness do-
main, as 8 items was deemed too much by patients. Then,
we looked at how the PRAQ could be best used for outcome
measurement. It is important that all items fit into a domain
that is either “coherent” in terms of clinical relevance, or
(preferably) in terms of covariance matrix as determined by
principal component analysis (PCA). Therefore, our aim was
to identify which items of the PRAQ can be grouped into
domains for outcome measurement after use of the results
of the PRAQ for an individual patient. We describe below
how we first reduced the number of items for the domain
‘sleepiness’, and then how from the remaining items a subset
of items was selected for outcome measurement.
Item reduction of the sleepiness domain
During the development of the PRAQ, patients indicated
that they felt that the number of items on the topic of
sleepiness could be reduced. Because they had no prefer-
ence for which items should be excluded, we took a
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statistical approach. We first looked for items with a high
inter-item correlation (> 0.9), indicating that one of these
items can be removed without a substantial loss of informa-
tion [17]. As a second step, we used exploratory factor ana-
lysis to identify potential items with lower factor loadings
(< 0.5), indicating that they do not cover the construct as
well as the other items and are therefore more suitable for
removal [17, 18].
Creating domains for the PRAQ-outcome
Two of our preliminary domains, ‘symptoms at night’ and
‘social interactions’, we considered formative rather than re-
flective domains: they do not aim to measure aspects of the
same latent construct, but the items are grouped together
based on clinical relevance. Grouping items in this way can
be considered a “clinimetric” approach, as opposed to a
“psychometric” approach which uses statistical methods to
determine the dimensionality of a PROM [19]. We wanted
to group these items together irrespective of their covari-
ance matrix, because for content reasons we did not con-
sider it desirable to combine these items with any of the
other (potential) domains. Therefore, we excluded them
from the PCA and kept these domains as they were.
We performed a PCA with oblique rotation (because cor-
relations between the different patient complaints were ex-
pected) on the 26 items of the other preliminary domains.
Items that did not load on any domain with a factor loading
of at least 0.5 or that had a factor loading of > 0.3 on more
than one factor [17], were then one by one removed from
the analysis, starting with those items that for content rea-
sons did not seem to fit well with the items they were
grouped with in the PCA. Additionally, since domains
should ideally consist of at least three items, we used this as
a requirement for the PRAQ-outcome domains [17]. The
one-dimensional domains that were identified by the ana-
lysis were added to the two clinimetric domains. Together,
these domains form the subset of the PRAQ that can be
used for outcome measurement.
Assessment of measurement properties
We studied the distribution of the individual items and
the PRAQ domain scores at baseline to check for floor
and ceiling effects (i.e. whether < 15% of the respondents
achieved the highest or lowest possible scores [20]). We
assessed the reliability, validity and responsiveness of the
PRAQ following the taxonomy of measurement proper-
ties as constructed by the COSMIN panel [21].
We calculated the internal consistency parameter
Cronbach’s alpha which should have a value between
0.70 and 0.95 [20]. We assessed test-retest reliability by
calculatingthe intraclass correlation coefficient (ICCcon-
sistency) for each PRAQ domain. ICC values of 0.7 are
considered acceptable, but values of ≥0.8 are preferred
[17]. Additionally, we calculated the standard error of
measurement (SEM).
We used hypothesis testing to assess convergent validity,
which involves studying the correlations of the scores of
the PROM under study with the scores of other PROMs.
We hypothesized on the size and direction of the (Spear-
man’s) correlations of the PRAQ domains with the (sub-
scales of) PROMs with similar constructs (Appendix 2).
We also hypothesized which PROMs should have a lower
correlation with the PRAQ domain. Good convergent val-
idity means that 75% of hypotheses are correct [20]. We
used the following (subscales of) PROMs for convergent
validity in their official Dutch translations:
 The Epworth Sleepiness Scale (ESS) [22], measuring
daytime sleep propensity. For eight situations, a patient
indicates the likelihood that they would fall asleep while
in that situation. The measurement properties of the
ESS have been studied in a sleep apnea population [23].
 The “vitality” domain of the RAND-36 [24]. The
(freely available) RAND-36, which is the predecessor
of the well-known SF-36, measures general quality
of life in several domains. The vitality domain of the
RAND-36 contains 4 items about a patient’s per-
ceived energy level. The items are identical to the
items of the vitality domain of the SF-36, and the
domain’s measurement properties have been studied
in a sleep apnea population in that context [23].
 The following short-forms of the Patient-Reported
Outcomes Measurement Information System (PRO-
MIS) databank [25–27]: sleep disturbance (5 items),
sleep-related impairment (6 items), fatigue, satisfac-
tion with participation in social roles, ability to par-
ticipate in social roles, anger, anxiety and depression
(the latter 6 all contained 4 items per short-form)
[28–31]. For “sleep disturbance” and “anger” these
were custom short-forms with fewer items than the
standard short forms, in order to reduce the number
of items that patients had to complete for this study.
To assess responsiveness, we constructed hypotheses
about the change scores of PRAQ in correlation to the
change scores of the same instruments that were employed
for hypothesis testing in construct validity (Appendix 2).
Results
Population characteristics
The baseline population consisted of 180 patients with
suspected OSA who completed the baseline measure-
ment. Of these patients, 105 completed the retest be-
tween 7 and 21 days (average 14 days), and 53 patients
completed the follow-up measurement after 6–8 weeks
of treatment with CPAP. Characteristics of these re-
spective (sub)populations can be found in Table 1.
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Missing data
Patients completing the online PRAQ were not allowed to
leave any items open (no missings allowed). Eleven patients
completed the PRAQ on paper one or more times, and in
one of these completed PRAQs (for follow-up after CPAP),
item 33 (Appendix 1) was missing from the domain “social
interactions”. We computed the domain score for this pa-
tient as the average of the remaining items.
Seven items allowed the response item “not applicable”
(see Appendix 1). Between 19 and 46% of respondents
selected this response category for the respective items.
Final stage of PRAQ development
Finishing the item selection of the sleepiness domain
None of the inter-item correlations in the preliminary
‘sleepiness’ domain was higher than 0.9. Principal compo-
nent analysis showed that the lowest factor loading was
0.65, well above 0.5. Therefore, we took practical elimin-
ation decisions: the two items with a “not applicable” op-
tion were removed (about sleepiness while reading, and
while driving a car) as well as an item about napping in
the afternoon that had a different answering scale than the
other items. This improves the homogeneity of the do-
main for patients. The final version of the PRAQ consists
of 10 domains and 40 items (Appendix 1).
Identification and grouping of items for outcome
measurement
The results of the final PCA can be found in Table 2. The
items of the PRAQ domains “memory & concentration”,
“sleep quality”, and “concerns about health” were removed
because they did not have sufficient loading on any of the
factors found in the PCA, or because the items loaded on
more than one factor. The items of the PRAQ domains
“tiredness” and “daily activities” loaded on a single factor ra-
ther than on two separate factors: these items were there-
fore combined in one domain called “energy & daily
activities” for the goal of outcome measurement. The items
of the PRAQ domain “unsafe situations” both loaded on
one separate domain. However, since this domain contained
only two items it was not added to the PRAQ-outcome.
The 19 remaining items in the PCA form three
one-dimensional domains: sleepiness, energy & daily activ-
ities, and emotions, which together explain 73% of the vari-
ance. The PCA showed intercorrelations of these domains
of 0.36–0.57. The domains are added to the two formative
domains “symptoms at night” and “social interactions”,
resulting in subset of 33 items in five domains. Figure 1 illus-
trates how the items and domains of the PRAQ result in the
subselection of PRAQ items for outcome measurement. The
domains that are present in both the full 40-item PRAQ and
in the 33-item outcome subset overlap to a great extent.
Measurement properties
In this section we describe the measurement properties of
the domains that are used for outcome measurement; the
results for the domains of the 40-item version can be found
in Additional file 1. The average baseline scores, standard
deviations, and percentages of lowest and highest scores of
the five outcome domains can be found in Table 3. No
floor- or ceiling effects were found, except for a floor effect
in the ‘sleepiness’ domain (20% of subjects scored 1–1.5).
The results of the different aspects of reliability (internal
consistency with Cronbach’s alpha, test-retest reliability with
ICC, SEM) are also shown in Table 3. The values of Cron-
bach’s alpha and the ICC values are all above 0.8, indicating
that these measurement properties are of good quality.
The correlations of the outcome domains with comparator
instruments, which were used to determine convergent val-
idity, are presented in Table 4. The correlations with the
(somewhat) similar constructs were all within the ranges that
we hypothesized (n = 14 hypotheses), and the correlations of
selected PRAQ-domains with the dissimilar constructs were
Table 1 Baseline characteristics of the study populations
Baseline population (n = 180) Test-retest population (n = 105) Population with follow-up after CPAP (n = 53)
Gender 31.7% female 38.1% female 25.0% female
Age (mean (SD)) 50.1 (12.6) 50.4 (13.0) 55.8 (10.9)
Baseline AHI (mean (SD)) 25 (23) (n = 160a) 27 (25) (n = 96a) 41 (22)
BMI (mean (SD)) 28.9 (4.7) 28.3 (4.6) 30.4 (4.2)
ESS score (mean (SD)) 9.9 (4.7) 9.6 (4.4) 9.8 (4.7)
ESS score≥ 11 43% 42% 40%
Sleep study (type) 43% PG /57% PSG (n = 160*) 39%PG /61% PSG (n = 96*) 43%PG/ 57%PSG
CPAP compliance (mean (SD)) N/A N/A 6:46 h (1:40 h)
CPAP compliance ≥4 h/night N/A N/A 96%
AHI with CPAP (mean(SD)) N/A N/A 2.6 (3.4)
AHI Apnea-Hyponea Index, BMI Body Mass Index, ESS Epworth Sleepiness Scale, PG = polygraphy, PSG polysomnography
a. 20 patients with suspected OSA of the total study population did for various reasons (choose to) not undergo a sleep study to determine their AHI
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all lower than those with the similar constructs (n = 3 hy-
potheses), as expected.
The absolute change scores of the PRAQ outcome do-
mains after patients were treated with CPAP ranged
from 0.76 (domain “emotions”) to 1.96 (domain “energy
& daily activities”) (Appendix 3). The correlations of the
change scores of the PRAQ and the change scores of the
comparator instruments (Table 5) were generally in
agreement with our hypotheses (n = 17 hypotheses). The
exception was the “emotions” domain of the PRAQ,
which did not correlate as strongly with the change
scores of the PROMIS domains about emotions (anger,
anxiety, depression; r = 0.26–0.43) as we had expected.
When a hypothesis is not met, it is important to identify
why the results are different than expected [32]. To gain
more insight into these unexpected scores, we therefore
ran an additional analysis on the correlation of the
PRAQ scores and the PROMIS scores at the follow-up
measurement, showing results of r = 0.62–0.71. This
shows that the discrepancy lies with the change score it-
self and not the absolute score of the follow-up
measurement.
Discussion
In this article we present the finalized Patient-Reported
Apnea Questionnaire (PRAQ). The PRAQ has a unique
approach with regard to the integration of use on an in-
dividual patient level and for aggregate outcome meas-
urement: patients complete all items of the PRAQ
before their consultation, the results of which can be
discussed with a healthcare professional; and the aggre-
gate outcomes of groups of patients can then be studied
by making use of a subset of the completed items. The
PRAQ contains all topics and items that patients and
healthcare providers consider important to discuss in
practice, and for this purpose includes 40 items in 10 do-
mains. For outcome measurement, a subset of 33 items of
the PRAQ was selected, divided into two formative do-
mains (items grouped together based on what makes sense
clinically) and three one-dimensional subscales. These five
outcome domains generally have good measurement prop-
erties in terms of internal consistency, test-retest reliability,
convergent validity and responsiveness.
PCA showed that items of the PRAQ domains “tired-
ness” and “daily activities” load on the same factor,
Table 2 Results of the principal component analysisab
Items Factor
1
Factor
2
Factor
3
During the past 4 weeks, did you have a problem with:
Fighting to stay awake during the day? .290 .727
Suddenly falling asleep? .836
Difficulty staying awake during a conversation? .636 .222
Difficulty staying awake while watching something? (concert, movie, television) .858
Falling asleep at inappropriate times or places? .802
Feeling very tired? .785
Lacking energy? .856
Still feeling tired when you wake up in the morning? .790
In the past 4 weeks:
How difficult was it for you to do your most important daily activity? (such as your job, studying, caring for the children,
housework)
.841
How often did you use all your energy on only your most important, daily activity? (such as your job, studying, caring for
the children, housework)
.940
How often did you use all your energy to accomplish only your most important daily activity? (such as your job, studying,
caring for the children, housework)
.825
How much difficulty did you have finding energy for your hobbies? .770
How difficult was it for you to get your chores done? .849
How often did you feel depressed or hopeless? .266 .677
How often did you feel anxious? .793
How often did you lose your temper? .803
How often did you feel that you could not cope with everyday life? .746
How often did you feel irritated? .889
How often did you have a strong emotional reaction to everyday events? .875
a. The bold font numbers indicate the highest factor loading for that item
b. Absolute factor loadings < 0.2 are not shown in the table
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Symptoms at night
6 items
Symptoms at night
6 items
Sleepiness
5 items
Tiredness
3 items
Daily activities
5 items
Unsafe situations
2 items
Social interactions
8 items
Memory &
Concentration
2 items
Quality of sleep
2 items
Emotions
6 items
Sleepiness
5 items
Energy & daily
activites
8 items
Emotions
6 items
Social interactions
8 items
Items excluded
for outcome
measurement after PCA
Health concerns
1 item
Domains/items of the
PRAQ
Subselection of domains/items for
outcome measurement
Fig. 1 The subselection of items and domains of the PRAQ for outcome measurement
Table 3 PRAQ outcome domains: scores and reliability parameters (n = 180)
Domain name Average (range 1–7) Standard deviation Lowest score (1–1.5) Highest score (6.5–7) Cronbach’s α ICCa SEMa
Sleepiness 3.13 1.57 20% 2.2% 0.88 0.81 0.69
Energy&daily activities 4.52 1.59 4.4% 7.8% 0.95 0.86 0.60
Emotions 2.89 1.28 13.3% 0.0% 0.92 0.85 0.50
Symptoms at night 3.48 1.27 3.9% 1.1% - b 0.88 0.44
Social Interactions 3.11 1.42 13.9% 0.6% - b 0.86 0.53
ICC = intraclass correlation efficient, SEM = standard error of measurement
a. n = 105
b. These domains are formative, and Cronbach’s α is only relevant when a domain is one-dimensional (36)
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which is why the items of these preliminary domains are
combined into one domain for the purpose of outcome
measurement. For use an individual patient level, how-
ever, we decided to keep the two domains separate. Even
though we acknowledge that feeling tired (a symptom),
and the extent to which daily activities can be performed
normally (a consequence of that symptom), are closely
related concepts, they may be relevant to discuss separ-
ately for an individual patient in clinical practice. We
will test this assumption in future research, in which the
PRAQ will be employed and studied empirically.
The domains that are used for outcome measurement
show good responsiveness. The one exception is the domain
“emotions”, the change score of which showed a much
weaker correlation than expected with the change scores of
PROMs with similar constructs. We hypothesize that the
discrepancy between expectation and results caused by the
low scores of this domain at baseline (average 2.89) and the
subsequent relatively small improvement that is achieved
after treatment with CPAP (average 0.76). We do not doubt
the construct validity of the domain, because the
comparator PROMs show the same pattern in terms of low
scores and small change scores, and because the correlation
of the absolute scores after treatment with CPAP shows
good convergent validity. However, because the change
scores are small, it is likely that measurement error plays a
relatively large role in the change scores of both the PRAQ
domain and the comparator instruments, reducing the ac-
curacy of the change scores and therefore also diffusing the
correlation size. This means that that in terms of outcome/
quality measurement, emotional problems appear to be of
less importance than the topics of the other domains and
more difficult to accurately measure, because relatively few
people with (suspected) OSA experience severe problems.
Surprisingly, 20% of the study population had low scores
(1–1.5) on the domain ‘sleepiness’, while sleepiness is one of
the main complaints of OSA. We think that this is due to a
relatively high difficulty of the sleepiness items of the PRAQ
(such as falling asleep during a conversation) in combin-
ation with a generally low sleepiness in this population
(average ESS < 10). This reason for the low sleepiness in the
population is probably twofold. First, the main complaint of
Table 4 Correlations PRAQ outcome domains and comparator instruments a (n = 180)
ESS PROMIS Sleep-
related
impairment
RAND
vitality
PROMIS
fatigue
PROMIS Ability to participatie in
Social Roles and Activities
PROMIS
Satisfaction Social
Roles
PROMIS anger/
anxiety/
depression
PROMIS sleep
disturbance
Sleepiness 0.67 0.60 −.40 .52
Energy &
daily
activities
0.45 0.83 −.77 0.86 −0.78 −0.60
Emotions 0.28 −0.59 0.56 −0.60 −0.42 0.69–0.76
Symptoms
at night
0.47
Social
interactions
0.56 −0.52 −0.39
ESS = Epworth Sleepiness scale, PROMIS = patient-reported outcomes measurement information system
a. Correlations in bold are considered similar constructs, for which detailed hypotheses were created. The other correlations are of (somewhat) different constructs
and are expected to be weaker than the bold font correlations for that PRAQ domain (for details, see Appendix 2).. Correlations for which we had no specific
expectations are not shown
Table 5 Correlations between change scores PRAQ outcome domains and comparator instruments a (n = 53)
ESS PROMIS Sleep-
related
impairment
RAND
vitality
PROMIS
fatigue
PROMIS Ability to participatie in
Social Roles and Activities
PROMIS
Satisfaction
Social Roles
PROMIS anger/
anxiety/
depression
PROMIS sleep
disturban-ce
Sleepiness .62 .55 −.35 .35
Energy&daily
activities
.52 .62 −.69 .70 −.74 −.61
Emotions 0.06 .23 −.32 .14 −.29 .26–.43
Symptoms at
night
.58
Social
interactions
.45 −.36 −.26
ESS = Epworth Sleepiness scale, PROMIS = Patient-Reported Outcomes Measurement Information System
a. Correlations in bold are considered similar constructs, for which detailed hypotheses were created. The other correlations are of (somewhat) different constructs
and are expected to be weaker than the bold font correlations for that PRAQ-outcome domain (for details, see Appendix 2). Correlations for which we had no
specific expectations are not shown
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some patients who were referred for suspected OSA in this
study is probably (socially problematic) snoring rather than
sleepiness or tiredness during the day. OSA treatment will
reduce snoring and is reimbursed by healthcare insurers,
making it beneficial for these patients to visit the sleep cen-
ter and get an OSA diagnosis. Second, for logistical reasons
some patients with suspected severe OSA were not in-
cluded in the study. These patients a fast- track procedure
to bypass the sleep center’s the waiting list, which meant
they were in practice not always asked to join the study.
This is a limitation of the study. What we can derive from
the current results is that the sleepiness domain of the
PRAQ seems more useful to detect cases of severe sleepi-
ness, which definitely requires treatment, than to distin-
guish mild and moderate sleepiness. However, future
research should take place in a more representative patient
group to study how the sleepiness domain performs in this
population.
The PRAQ is designed for use in clinical practice, to
help focus consultations on the problems that individual
patients encounter. When using a PROM for this pur-
pose, the ICC should preferably be very high (0.9–0.95
at individual level vs. 0.8 or higher at group level for ag-
gregate outcome measurement [17]). The ICC values of
the PRAQ are lower (0.81–0.88). However, the PRAQ is
meant to open the conversation about a patient’s symp-
toms and functioning, not to serve as a “cut-off” score.
Any elevated score could therefore result in conversation
about this topic, and we believe that the PRAQ can
serve its purpose despite the slightly lower ICCs.
Methodological considerations
The domains for outcome measurement were created
with a combination of the “clinimetric” approach, in
which items are grouped together based on clinical rele-
vance; and the “psychometric” approach, which groups
items together based on PCA [33–35]. The combination
of these two approaches is uncommon. We believe that
scores of psychometric domains, with a clear
one-dimensional construct, are more meaningful than
formative domains because they have a clear interpret-
ation. However, this approach is not always feasible
when items have been selected to be part of a
quality-of-life or symptoms questionnaire based on their
deemed importance by the target population [36]. Items
which cover symptoms of the same disease or treatment
will often share covariance and thus appear to be cover-
ing the same latent construct, even when looking at the
content of the items this makes no apparent sense (e.g.
lack of appetite and decreased sexual interest in patients
undergoing cancer treatment [36]). Therefore, we con-
sidered the best approach grouping together the differ-
ent symptoms patients experience at night, as well as
the variety of different ways in which sleepiness, tired-
ness and emotions might influence a patients’ social life,
without subjecting them to PCA.
To aid the use of the PRAQ in clinical practice, we devel-
oped a patient-friendly digital report (the PRAQ-report) to-
gether with patients and healthcare professionals (Fig. 2).
When using the PRAQ in clinical practice, it can be useful
to look at individual item scores as well as the domain
scores, especially in the formative domains in which item
scores will generally differ more from each other. There-
fore, both domain and individual item scores are shown in
the report.
Conclusions
In conclusion, we have shown that the PRAQ-practice
and PRAQ-outcome generally have acceptable measure-
ment properties and appear to be suitable PROMs for
their respective purposes. However, further validation re-
search is needed in patients who suffer from higher
levels of sleepiness, to study the validity of the sleepiness
domain. The applicability of a PROM for use in clinical
practice and for measuring outcomes on aggregate level,
Fig. 2 The first page of the PRAQ-report
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Appendix 1
Table 6 The Patient-Reported Apnea Questionnaire (PRAQ)
Symptoms at night
During the past 4 weeks, did you have a problem with:
1. Snoring loudly?
2. Waking up frequently to urinate?
3. Waking up at night with the feeling that you are choking?
4. A feeling that you are sleeping restlessly?
5. Having a dry or painful mouth when you wake up?
6. Waking up in the morning with a headache?
Sleepiness
During the past 4 weeks, did you have a problem with:
7. Fighting to stay awake during the day?
8. Suddenly falling asleep?
9. Difficulty staying awake during a conversation?
10. Difficulty staying awake while watching something? (concert, movie, television)
11. Falling asleep at inappropriate times or places?
Difficulty staying awake while reading?a,b
Fighting to stay awake when you are driving?a,b
Did you feel like you needed to take a nap in the afternoon?a
Tiredness
During the past 4 weeks, did you have a problem with:
12. Feeling very tired?
13. Lacking energy?
14. Still feeling tired when you wake up in the morning?
Daily activities
During the past 4 weeks:
15. How difficult was it for you to do your most important daily activity? (such as your job, studying, caring for the children, housework)
16. How often did you use all your energy to accomplish only your most important daily activity? (such as your job, studying, caring for the children, housework)
17. Did you feel you have a decreased performance with regard to your most important daily activity? (such as your job, studying, caring for the children, housework)
18. How much difficulty did you have finding energy for your hobbies?
19. How difficult was it for you to get your chores done?
Unsafe situations
During the past 4 weeks:
20. Did you have problems while driving a car due to sleepiness?b
21. Were you concerned about your safety or that of others due to your sleepiness? (for example in traffic, or when operating machinery)
Memory and concentration
During the past 4 weeks:
22. Were you sometimes forgetful?
23. Did you sometimes have difficulty concentrating?
Quality of sleep
During the past 4 weeks, did you have a problem with:
24. Falling asleep when you go to bed at night?
25. Getting back to sleep after you woke up at night?
Emotions
During the past 4 weeks:
26. How often did you feel depressed or hopeless?
27. How often did you feel anxious?
28. How often did you lose your temper?
29. How often did you feel that you could not cope with everyday life?
30. How often did you feel irritated?
31. How often did you have a strong emotional reaction to everyday events?
Social interactions
During the past 4 weeks:
32. Did you sometimes feel upset because others were disturbed by your snoring?
33. Was it a problem for you that you sometimes had no energy or no desire to do things with your family or your friends?
34. Did you feel guilty towards your family or friends?
35. Did you feel upset because you argued frequently?
36. Did you sometimes experience problems in the relationship with your partner?b
37. Did you feel upset because you could (maybe) not sleep in the same room as your partner?b
38. Did you sometimes think up excuses because you were tired or sleepy?
39. Did you have a problem with unsatisfying and/or too little sexual activity? (by yourself or with another)b
Health concerns
40. Were you concerned about other conditions that may be related to sleep apnea? (such as diabetes, high blood pressure, cardiovascular disease, being overweight)
a. The shaded items of the “sleepiness” domain were removed from this domain in the final version of the PRAQ
b. These items had an additional response option “not applicable” or (for item 39) “no answer”
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Appendix 2
Table 7 Hypotheses for convergent validity and responsiveness
PRAQ
domain
Comparison instrument Expected correlation
strength (direction)
Explanation (hypothesis nr between brackets)
Sleepiness ESS 0.5–0.8 (+) The ESS asks about current daytime sleep propensity, while the PRAQ domain
asks to look back on the past month and indicate how much of a problem
sleepiness or falling asleep was. The domains do not cover the exact same
construct, but are relatively similar. We expect a moderately strong correlation
(h1).
“Sleep-related impairment” is a domain with questions covering both
sleepiness and tiredness. We expect a moderate to strong correlation with the
PRAQ domain “sleepiness” (h2) because of the overlapping items on
sleepiness, but also because the concept of sleepiness itself correlates with
the concept of tiredness and how tiredness affects daily activities in our study
population (correlation strength 0.57 as found in our principal component
analysis).
Dissimilar constructs
We expect the correlations with the PROMIS fatigue and RAND-36 vitality do-
mains to be lower than the correlations with the similar constructs of the
PROMs mentioned above (h3).
PROMIS: Sleep-related
impairment
0.5–0.8 (+)
Different constructs
PROMIS fatigue (+)
RAND-36 vitality (−)
Energy &
daily
activities
PROMIS: Sleep-related
impairment
0.6–0.9 (+) “Sleep-related impairment” is a domain with questions covering both
sleepiness and tiredness, in the context of daily activities. Therefore we expect
a strong correlation with the PRAQ domain (h1).
The RAND-36 vitality domain and the PROMIS fatigue both contain questions
about tiredness. We expect both to have a strong correlation with the PRAQ
domain (h2 + 3). We expect a somewhat stronger (h4) correlation with the
PROMIS fatigue domain because this domain is focused on to what extent
one feels tired (similar to the PRAQ), while the RAND focuses on how often
one feels tired.
The PROMIS domain “ability to participate in social roles and activities” asks
question about to what extent someone is able to do their usual daily or
social activities. We expect a strong correlation with the PRAQ domain
because the constructs are similar (h5).
Dissimilar constructs
We expect the correlations with the ESS and the “PROMIS satisfaction with
social roles and activities” domain to be lower than the correlations with the
similar constructs of the PROMs mentioned above (h6).
RAND-36 vitality 0.6–0.9 (−)
PROMIS Fatigue 0.6–0.9 (+)
PROMIS ability to participate
in social roles and activities
0.6–0.9 (−)
Different constructs
PROMIS satisfaction with social roles and activities (−)
ESS (+)
Emotions PROMIS anger 0.6–0.9 (+) The three PROMIS domains contain items asking about how often certain
emotions are felt, which is the same approach as the PRAQ-domain. The
PRAQ-domain also contains all three of these types of emotions. Therefore we
expect a strong correlation with all three of these domains (h1–3).
Dissimilar constructs
We expect the correlations of the PRAQ “emotions” domain with the ESS,
RAND-36, and the PROMIS domains ability to participate in social roles and ac-
tivities and “satisfaction with social roles and activities” to be lower than the
correlations with the similar constructs of the PROMs mentioned above (h4).
PROMIS anxiety 0.6–0.9 (+)
PROMIS depression 0.6–0.9 (+)
Different constructs
ESS (+)
RAND-36 vitality (−)
PROMIS ability to participate in social roles and
activities (−)
PROMIS satisfaction with social roles and activities (−)
Symptoms
at night
PROMIS sleep disturbance 0.2–0.6 (+) The most similar domain that we included for the PRAQ domain “symptoms
at night” is the PROMIS “sleep disturbance” domain. This domain contains
items about whether patients are sleeping well. Even though a majority of the
items in the PRAQ domain “symptoms at night” will affect the quality of sleep,
the content of the two domains is very different. We therefore will not make a
very precise hypothesis, and expect at least a low to moderate correlation
(h1).
Dissimilar constructs are not included for this domain. Due to the domain’s
clinimetric nature it covers several topics that are related to severity of OSA
and that might therefore have unpredictable correlations with other domains.
Social
interactions
PROMIS: Sleep-related
impairment
0.2–0.6 (+) The “social interactions” domain of the PRAQ contains a collection of items
about different social problems that apnea patients might experience due to
their snoring, sleepiness, tiredness, or emotions. Because this domain does not
clearly cover one single construct, we expect it to have no more than low to
moderate correlations with any of the comparator PROMIS domains (h1–3).
Dissimilar constructs are not included for this domain. Due to the domain’s
clinimetric nature it covers several topics that are related to severity of OSA
and that might therefore have unpredictable correlations with other domains.
PROMIS ability to participate
in social roles and activities
0.2–0.6 (−)
PROMIS satisfaction with
social roles and activities
0.2–0.6 (−)
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may be of great importance for the further implementa-
tion of PROMs in healthcare.
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Additional file 1: Domain and reliability scores of the PRAQ clinical
practice domains. (DOCX 17 kb)
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